Search Results - "Prudhon, Bernard"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model by Fongy, Anaïs, Falcone, Sestina, Lainé, Jeanne, Prudhon, Bernard, Martins-Bach, Aurea, Bitoun, Marc

    Published in Scientific reports (07-02-2019)
    “…Dynamin 2 (DNM2) is a key protein of the endocytosis and intracellular membrane trafficking machinery. Mutations in the DNM2 gene cause autosomal dominant…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations by Dudhal, Swati, Mekzine, Lylia, Prudhon, Bernard, Soocheta, Karishma, Cadot, Bruno, Mamchaoui, Kamel, Trochet, Delphine, Bitoun, Marc

    Published in Molecular therapy. Nucleic acids (13-09-2022)
    “…Dominant centronuclear myopathy (CNM) is a rare form of congenital myopathy associated with a wide clinical spectrum, from severe neonatal to milder adult…”
    Get full text
    Journal Article
  4. 4

    A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice by Durieux, Anne-Cécile, Vignaud, Alban, Prudhon, Bernard, Viou, Mai Thao, Beuvin, Maud, Vassilopoulos, Stéphane, Fraysse, Bodvaël, Ferry, Arnaud, Lainé, Jeanne, Romero, Norma B., Guicheney, Pascale, Bitoun, Marc

    Published in Human molecular genetics (15-12-2010)
    “…Autosomal dominant centronuclear myopathy (AD-CNM) is due to mutations in the gene encoding dynamin 2 (DNM2) involved in endocytosis and intracellular membrane…”
    Get full text
    Journal Article
  5. 5

    Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfalls by Trochet, Delphine, Prudhon, Bernard, Vassilopoulos, Stéphane, Bitoun, Marc

    Published in Current gene therapy (01-01-2015)
    “…RNA interference (RNAi) is a conserved mechanism for post-transcriptional gene silencing mediated by messenger RNA (mRNA) degradation. RNAi is commonly induced…”
    Get more information
    Journal Article
  6. 6

    Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy by Trochet, Delphine, Prudhon, Bernard, Mekzine, Lylia, Lemaitre, Mégane, Beuvin, Maud, Julien, Laura, Benkhelifa-Ziyyat, Sofia, Bui, Mai Thao, Romero, Norma, Bitoun, Marc

    Published in Molecular therapy. Nucleic acids (08-03-2022)
    “…Dominant dynamin 2 (DNM2) mutations are responsible for the autosomal dominant centronuclear myopathy (AD-CNM), a rare progressive neuromuscular disorder…”
    Get full text
    Journal Article
  7. 7

    Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy by Azibani, Feriel, Brull, Astrid, Arandel, Ludovic, Beuvin, Maud, Nelson, Isabelle, Jollet, Arnaud, Ziat, Esma, Prudhon, Bernard, Benkhelifa-Ziyyat, Sofia, Bitoun, Marc, Lorain, Stéphanie, Bonne, Gisèle, Bertrand, Anne T.

    Published in Molecular therapy. Nucleic acids (02-03-2018)
    “…We assessed the potential of Lmna-mRNA repair by spliceosome-mediated RNA trans-splicing as a therapeutic approach for LMNA-related congenital muscular…”
    Get full text
    Journal Article
  8. 8

    A Centronuclear Myopathy – Dynamin 2 Mutation Impairs Autophagy in Mice by Durieux, Anne‐Cécile, Vassilopoulos, Stéphane, Lainé, Jeanne, Fraysse, Bodvaël, Briñas, Laura, Prudhon, Bernard, Castells, Josiane, Freyssenet, Damien, Bonne, Gisèle, Guicheney, Pascale, Bitoun, Marc

    Published in Traffic (Copenhagen, Denmark) (01-06-2012)
    “…Dynamin 2 (Dnm2) is involved in endocytosis and intracellular membrane trafficking through its function in vesicle formation from distinct membrane…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing by Trochet, Delphine, Prudhon, Bernard, Jollet, Arnaud, Lorain, Stéphanie, Bitoun, Marc

    Published in Molecular therapy. Nucleic acids (13-09-2016)
    “…Dynamin 2 (DNM2) is a large GTPase, ubiquitously expressed, involved in membrane trafficking and regulation of actin and microtubule cytoskeletons. DNM2…”
    Get full text
    Journal Article
  11. 11

    Dynamin 2 and human diseases by Durieux, Anne-Cécile, Prudhon, Bernard, Guicheney, Pascale, Bitoun, Marc

    “…Dynamin 2 (DNM2) mutations cause autosomal dominant centronuclear myopathy, a rare form of congenital myopathy, and intermediate and axonal forms of…”
    Get full text
    Journal Article
  12. 12

    Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset by Bitoun, Marc, Bevilacqua, Jorge A., Prudhon, Bernard, Maugenre, Svetlana, Taratuto, Ana Lia, Monges, Soledad, Lubieniecki, Fabiana, Cances, Claude, Uro-Coste, Emmanuelle, Mayer, Michèle, Fardeau, Michel, Romero, Norma B., Guicheney, Pascale

    Published in Annals of neurology (01-12-2007)
    “…We report four heterozygous dynamin 2 (DNM2) mutations in five centronuclear myopathy patients aged 1 to 15 years. They all presented with neonatal hypotonia…”
    Get full text
    Journal Article
  13. 13

    Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis by Bitoun, Marc, Durieux, Anne-Cécile, Prudhon, Bernard, Bevilacqua, Jorge A, Herledan, Adrien, Sakanyan, Vehary, Urtizberea, Andoni, Cartier, Luis, Romero, Norma B, Guicheney, Pascale

    Published in Human mutation (01-10-2009)
    “…Dynamin 2 (DNM2) is a large GTPase involved in the release of nascent vesicles during endocytosis and intracellular membrane trafficking. Distinct DNM2…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings by Bitoun, Marc, Stojkovic, Tanya, Prudhon, Bernard, Maurage, Claude-Alain, Latour, Philippe, Vermersch, Patrick, Guicheney, Pascale

    Published in Neuromuscular disorders : NMD (01-04-2008)
    “…Abstract Mutations in dynamin 2 (DNM2) have been associated with autosomal dominant centronuclear myopathy, dominant intermediate Charcot-Marie-Tooth (CMT)…”
    Get full text
    Journal Article
  17. 17

    Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice by CARRIER, Lucie, KNÖLL, Ralph, SCHWARTZ, Ketty, CHIEN, Kenneth R, VIGNIER, Nicolas, KELLER, Dagmar I, BAUSERO, Pedro, PRUDHON, Bernard, ISNARD, Richard, AMBROISINE, Marie-Lory, FISZMAN, Marc, ROSS, John JR

    Published in Cardiovascular research (01-08-2004)
    “…Cardiac myosin-binding protein C (cMyBP-C) gene mutations are involved in familial hypertrophic cardiomyopathy (FHC). Many of these mutations produce truncated…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster by Serose, Armelle, Prudhon, Bernard, Salmon, André, Doyennette, Marie-Agnès, Fiszman, Marc Y, Fromes, Yves

    Published in Basic research in cardiology (01-03-2005)
    “…Dilated cardiomyopathies (DCM) are due to progressive dilatation of the cardiac cavities and thinning of the ventricular walls and lead unavoidably to heart…”
    Get full text
    Journal Article
  20. 20